Condition
Amblyopia, Anisometropic
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07226141Phase 1Not Yet Recruiting
Valproate for the Treatment of Residual Amblyopia
NCT07093840Not ApplicableCompletedPrimary
Multimodal Therapy in Anisometropic Amblyopia
NCT05620173Not ApplicableActive Not RecruitingPrimary
Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT)
NCT04213066Not ApplicableCompleted
Stochastic Resonance Applied to Amblyopia Training and the Plasticity of Brain
NCT02970708Not ApplicableUnknownPrimary
Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia
Showing all 5 trials